Patient population
There were 4634 unique patients enrolled in our program from 1991-2017.
A total of 2572 met the inclusion and exclusion criteria and were
included in the study. While patients were enrolled from anywhere from
one month to 12 months in the program we reviewed the data of the first
three months of the program. The baseline characteristics of the
patients are in Table 1. Among 2572 patients a total of 1176 (73.1%
female; 26.9% male) patients had IFG with fasting blood glucose between
100 mg/dL and 125 mg/mL and 1396 patients (77.8% female; 22.2% male)
were found to having normal fasting glucose of < 100 mg/dL.
The groups were found to be statistically different with the average
patient being older and at a greater BMI in the IFG group.
Other than appointment reminders for patients who missed two consecutive
weekly appointments, there were no efforts at retention. There were 843
patients remaining in the normal fasting glucose group and 755 patients
remaining in the IFG group at the end of 3 months. Patients who left the
program and ones remained in the program but who missed 3 weekly visits
for any reason were not included in the analysis. There were 421
patients left the program at month 3 in the IFG group.